81 related articles for article (PubMed ID: 18476579)
1. [Study on a 10-year protective effects of vaccination against hemorrhagic fever with renal syndrome].
Gong ZY; Weng JQ; Lei JB; Fang CF; Chen EF; Wang Z; Chen ZB; Wang W; He F; Liu BY; Lin JF; Ding GQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Dec; 28(12):1190-3. PubMed ID: 18476579
[TBL] [Abstract][Full Text] [Related]
2. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
Gong ZY; Weng JQ; Zhao ZY; Chen YT; Zhu AG; Fu GM; Fang CF; Zhu ZY; Chen EF; Wang CZ; Wang W; Lei LH; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):400-2. PubMed ID: 15231163
[TBL] [Abstract][Full Text] [Related]
3. [The changes in serum antibody level after immunization with HFRS vaccine].
Gong Z; Weng J; Zhao Z; Lan J; Chen Y; Lin C; Fu G; Zhu Z; Xia J; Ji Q; Xu J; Wang C; Yu X; Wang W; Fang C
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Nov; 34(6):351-3. PubMed ID: 11860948
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of subclinical infection rates between vaccinated group with type I inactivated vaccine against hemorrhagic fever and controls].
Ruan Y; Xu X; Shao S; Tong Z; Weng S; Zhou W; Gu H; Zhu Z; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):308-10. PubMed ID: 11864500
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological characteristics and the strategy of vaccination on hemorrhagic fever with renal syndrome in the last 10 years, in China].
Luo CW; Chen HX
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1017-9. PubMed ID: 19173887
[TBL] [Abstract][Full Text] [Related]
7. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of HFRS vaccination against hemorrhagic fever with renal syndrome during 1999-2000 in Laiwu City].
Wei K; Xie Y; Yao Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):283-5. PubMed ID: 12665942
[TBL] [Abstract][Full Text] [Related]
9. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
[TBL] [Abstract][Full Text] [Related]
10. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
[TBL] [Abstract][Full Text] [Related]
11. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
Chen H; Tang L; Luo Z; Zhang J; Zhang Z; Hu M; Weng J; Liu W; Zhao T; Liu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
[TBL] [Abstract][Full Text] [Related]
12. [Long term epidemiological effects of vaccination on hemorrhagical fever with renal syndrome (HFRS) in Shaanxi provincial HFRS epidemic areas].
Wang JJ; Wei ZZ; Wei J; Ma CA; Dong JH; Lu XL; Zheng Y; Yu PB; Qu JH; Dong LF
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):309-12. PubMed ID: 22613385
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
Baysal B; Tosun S; Ozdemir M; Doğan M
Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
[TBL] [Abstract][Full Text] [Related]
14. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
[TBL] [Abstract][Full Text] [Related]
16. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
[TBL] [Abstract][Full Text] [Related]
17. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
18. The impact of the vaccination program for hemorrhagic fever with renal syndrome in Hu County, China.
Xiao D; Wu K; Tan X; Yan T; Li H; Yan Y
Vaccine; 2014 Feb; 32(6):740-5. PubMed ID: 24252696
[TBL] [Abstract][Full Text] [Related]
19. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
